Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to demonstrate the safety and effectiveness of the use of NMB's percutaneous transluminal angioplasty (PTA) for the treatment of obstructive lesions of Arteriovenous (AV) Dialysis Fistulae/Grafts.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Fistula
  • Obstructive Lesions of Arteriovenous Dialysis Fistulae

NCT number NCT01646788
Study type Interventional
Source N.M.B. Medical Applications Ltd
Contact Eli Atar, MD
Phone 972-3-9376389
Email elia@clalit.org.il
Status Not yet recruiting
Phase N/A
Start date January 2013
Completion date January 2015

See also
  Status Clinical Trial Phase
Not yet recruiting NCT01538108 - Study of NMB (Company's Name) Drug Ejecting Balloon for Arteriovenous Fistulae N/A